Tag: https://www.bio.org/events/bio-international-convention

Nov 24
Is CRISPR the New Sickle Cell Savior?

2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle […]

Nov 23
A Doctor Fights to Save His Own Life: The David Fajgenbaum Story.

David Fajgenbaum was in his third year of medical school when he was diagnosed with a rare and life-threatening disease that began shutting down his organs, bringing him perilously close to death. Although he survived the initial episode, he faced four additional relapses, each pushing him to the brink of death. In this episode, we […]

Nov 22
We Need Bees. Bees Need Biotech. (REDUX)

Bees and other pollinators are critical to our survival, with one out of every three bites of food we eat depending on pollination to produce. That’s why reports of a decline in bee populations and rising threats from pests, viruses and environmental pressures, including climate change, are alarming. In this episode we talk with an […]

Nov 21
How Will We Secure our Food Future?

As the global population approaches 10 billion by 2050, the challenge of providing safe, nutritious food is growing more urgent. Climate change is further straining food systems, impacting water availability, crop yields, and livestock health. In this episode, two experts discuss innovative biotech solutions aimed at addressing these pressing issues, offering hope for a sustainable […]

Nov 20
Biotech Women Striking at the Glass Ceiling

Follow us on LinkedIn (https://www.linkedin.com/company/biotechnology-innovation-organization/posts/?feedView=all) , X (https://twitter.com/IAmBiotech) , Facebook (https://www.facebook.com/IAmBiotech/) and Instagram (https://www.instagram.com/iambiotech/) .  Visit us at https://www.bio.org/ The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of […]

Nov 19
Cracking the Code on Pain Relief (Redux)

Imagine living with excruciating pain that prevents you from walking or doing the things most of us take for granted. We all experience pain, and 50 million people cope with chronic, debilitating pain. The market for pain therapies is estimated at $74 billion. And yet, investment in new pain and addiction treatments is falling short […]

Nov 18
Biotechnology is a National Security Asset

Since Watson and Crick discovered DNA’s double helix structure in 1953, the US has been a leader in biotechnology innovation. American excellence in this field has greatly benefited people around the world. In this episode, we talk about why this leadership position may be threatened and why that matters to our national security. Follow us […]

Nov 16
The Synbio Revolution is Here (REDUX)

Innovative companies are using synthetic biology to engineer organisms and create new materials that could transform every sector of our economy, from health care to food and energy production. Those companies say we’ve entered a synbio revolution, and it holds potential to improve the health of people and our planet. In this episode, we talk […]

Nov 15
“On My Own”—Desperate to Stop a Resistant Bacterial Infection

Bradley Burnam woke up one morning, looked in the mirror and found one ear twice it’s normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience took him from patient to […]

Nov 14
Biotech Women Striking at the Glass Ceiling (REDUX)

The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led companies in biotech. Our guests speak to why women’s leadership matters and the barriers that […]